Two Growth Stocks Positioned to Crush Market Returns by 2031

What Makes These Growth Stocks Worth Your Attention?

Everyone wants to beat the market, but few achieve it consistently over extended periods. Yet there are certain companies trading today that possess the fundamentals and growth trajectories to deliver above-average returns through the end of this decade. Let’s examine Intuitive Surgical (NASDAQ: ISRG) and Meta Platforms (NASDAQ: META), two growth stocks with compelling long-term potential.

Intuitive Surgical: Surgical Innovation as a Market Driver

While Intuitive Surgical has faced near-term headwinds—including tariff pressures and rising competitive intensity in robotic-assisted surgery—the company’s long-term picture remains attractive.

The da Vinci System Evolution

The latest iteration of Intuitive’s da Vinci system introduces Force Feedback Technology, allowing surgeons greater tactile sensitivity during procedures. This enhancement improves surgical precision and patient outcomes, likely driving adoption among healthcare providers and patients alike. As one of the company’s most recent launches, this technology is still in early adoption phases, suggesting significant room for penetration gains over the coming years.

Expanding Procedure Approvals

New indication approvals represent another substantial growth lever. Intuitive recently secured multiple new approvals for its da Vinci platform, expanding the addressable market for robotic-assisted procedures. These regulatory wins should boost procedure volumes, directly supporting revenue expansion.

Pricing Power as a Competitive Moat

Despite tariff challenges, Intuitive possesses genuine pricing power thanks to its proven ability to improve clinical outcomes. The company’s dominant market position and established installed base mean modest price increases could meaningfully offset cost pressures. While competition from other medical device manufacturers exists, the robotic-assisted surgery market remains underpenetrated globally—creating room for multiple winners.

Meta Platforms: AI Investments Finally Delivering

Meta’s recent earnings disappointed some investors worried that massive AI spending won’t justify returns. However, the narrative deserves reconsideration.

AI Delivering Tangible Revenue Growth

Meta’s AI-powered recommendation algorithms have meaningfully boosted user engagement across its platforms, while automated ad campaign tools have streamlined advertiser spending. Both have contributed to solid revenue and earnings growth. The company’s ambition to fully automate ad campaigns by 2026 could unlock even greater efficiencies.

Flexibility and Course Correction

Skeptics point to Meta’s metaverse investments as a cautionary tale—the company poured billions into an ambition that never materialized as hoped. Yet that very episode demonstrated Meta’s organizational flexibility. When metaverse spending and broader economic headwinds threatened profitability, management successfully right-sized costs, refocused on its highly profitable advertising core, and emerged strengthened. This same adaptability should apply to current AI investments.

Scale Advantage

With over 3 billion daily active users across its ecosystem, Meta possesses unmatched distribution for monetizing AI advancements. This scale advantage, combined with demonstrated ability to pivot when necessary, makes the company’s AI strategy increasingly likely to pay off.

The Growth Stock Opportunity

Both Intuitive Surgical and Meta Platforms offer growth stock characteristics that could lead to market-beating returns through 2031. Intuitive’s innovation pipeline and surgical procedure market tailwinds suggest sustained upside, while Meta’s AI prowess and proven operational flexibility provide confidence in navigating investor concerns. For investors seeking exposure to genuine growth drivers, these two companies warrant serious consideration.